223 related articles for article (PubMed ID: 28801137)
1. The challenges of treating recurrent polymorphic ventricular tachycardia due to coronary vasospasm: Lessons from an interesting case.
Trehan N; Rehman MU; Kottam A
J Electrocardiol; 2017; 50(6):972-974. PubMed ID: 28801137
[TBL] [Abstract][Full Text] [Related]
2. Coronary spasm: a case of transient ST elevation and syncopal ventricular tachycardia without angina.
Postorino C; Gallagher MM; Santini L; Magliano G; Chiricolo G; Bindo M; Postorino A; Romeo F
Europace; 2007 Aug; 9(8):568-70. PubMed ID: 17517803
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter defibrillator (ICD) for polymorphic ventricular tachycardia (VT) due to coronary vasospasm.
Bhat PK; Quan KJ
J Hosp Med; 2009 Jul; 4(6):E23-5. PubMed ID: 19670386
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic procedures for coronary vasospasm-induced polymorphic ventricular tachycardia.
Dresen WF; Wells QS; Maron DJ; McPherson JA
Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):115-21. PubMed ID: 22547691
[TBL] [Abstract][Full Text] [Related]
5. Multiple episodes of ventricular tachycardia induced by silent coronary vasospasm.
Sovari AA; Cesario D; Kocheril AG; Brugada R
J Interv Card Electrophysiol; 2008 Apr; 21(3):223-6. PubMed ID: 18297382
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery spasm as a cause of ST elevation and inappropriate implantable cardioverter defibrillator intervention.
Mascioli G; Bontempi L; Racheli M; Cerini M; Curnis A; Cas LD
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1055-7. PubMed ID: 18163021
[TBL] [Abstract][Full Text] [Related]
7. Aborted sudden cardiac death due to intractable ventricular fibrillation caused by coronary spasm refractory to implantable cardioverter defibrillator therapy.
Goto K; Kurabayashi M; Nakamura T; Asano M; Suzuki H; Shimura T; Sasano T; Hirao K; Isobe M; Okishige K
Int J Cardiol; 2014 Oct; 176(3):e133-4. PubMed ID: 25127979
[No Abstract] [Full Text] [Related]
8. Polymorphic ventricular tachycardia induced by coronary vasospasm: a malignant case of variant angina.
Yuksel UC; Celik T; Iyisoy A; Kursaklioglu H; Amasyali B; Kose S
Int J Cardiol; 2007 Oct; 121(2):210-2. PubMed ID: 17125857
[TBL] [Abstract][Full Text] [Related]
9. Variant Angina and Aborted Sudden Cardiac Death.
Kundu A; Vaze A; Sardar P; Nagy A; Aronow WS; Botkin NF
Curr Cardiol Rep; 2018 Mar; 20(4):26. PubMed ID: 29520510
[TBL] [Abstract][Full Text] [Related]
10. Should an implanted defibrillator be considered in patients with vasospastic angina?
Eschalier R; Souteyrand G; Jean F; Roux A; Combaret N; Saludas Y; Clerfond G; Barber-Chamoux N; Citron B; Lusson JR; Brugada P; Motreff P
Arch Cardiovasc Dis; 2014 Jan; 107(1):42-7. PubMed ID: 24373622
[TBL] [Abstract][Full Text] [Related]
11. Vasospastic angina without flow-limiting coronary lesions as a cause for aborted sudden death.
Lacroix D; Kacet S; Lekieffre J
Int J Cardiol; 1994 Mar; 43(3):247-9. PubMed ID: 8181882
[TBL] [Abstract][Full Text] [Related]
12. Recurrent ventricular fibrillation caused by coronary artery spasm leading to implantable cardioverter defibrillator implantation.
Hendriks ML; Allaart CP; Bronzwaer JG; Res JJ; de Cock CC
Europace; 2008 Dec; 10(12):1456-7. PubMed ID: 18978363
[TBL] [Abstract][Full Text] [Related]
13. Stent and implantable cardioverter defibrillator implantation in medically resistant vasospastic angina patient.
Özyüncü N; Göksülük H; Vurgun VK; Yıldırım O; Tan Kürklü TS
Turk Kardiyol Dern Ars; 2017 Oct; 45(7):641-645. PubMed ID: 28990946
[TBL] [Abstract][Full Text] [Related]
14. Recurrent ventricular arrhythmias and myocardial infarctions associated with cocaine induced reversible coronary vasospasm.
Yildirim AB; Basarici I; Kucuk M
Cardiol J; 2010; 17(5):512-7. PubMed ID: 20865684
[TBL] [Abstract][Full Text] [Related]
15. Effects of flecainide therapy on inappropriate shocks and arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
Jacquemart C; Ould Abderrahmane F; Massin MM
J Electrocardiol; 2012; 45(6):736-8. PubMed ID: 22672791
[TBL] [Abstract][Full Text] [Related]
16. Secondary prevention of sudden cardiac death in coronary artery spasm: is implantable cardioverter defibrillator always efficient?
Letsas KP; Filippatos GS; Efremidis M; Sideris A; Kardaras F
Int J Cardiol; 2007 Apr; 117(1):141-3. PubMed ID: 17046086
[TBL] [Abstract][Full Text] [Related]
17. Coronary vasospasm and aborted sudden death treated with an implantable defibrillator and stenting.
Fiocca L; Di Biasi M; Bruno N; Ciuffreda M; Zumbo F; Mangiameli D; Montenero AS
Ital Heart J; 2002 Apr; 3(4):270-3. PubMed ID: 12025377
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
[TBL] [Abstract][Full Text] [Related]
19. A Memorable Telemetry Diagnosis of Transient "Tombstone" ST-Segment Elevations Instigating Ventricular Fibrillation.
El-Zein R; Shah A; Chopra N
JACC Clin Electrophysiol; 2019 Dec; 5(12):1475-1476. PubMed ID: 31857049
[No Abstract] [Full Text] [Related]
20. Flecainide suppresses defibrillator-induced storming in catecholaminergic polymorphic ventricular tachycardia.
Hong RA; Rivera KK; Jittirat A; Choi JJ
Pacing Clin Electrophysiol; 2012 Jul; 35(7):794-7. PubMed ID: 22553997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
